A multicenter, prospective, non-interventional cohort study to evaluate the safety and treatment pattern of sodium zirconium cyclosilicate for hyperkalaemia management in real world practice in China - ACTUALIZE

Study identifier:D9483R00001

ClinicalTrials.gov identifier:NCT05271266

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A multicenter, prospective, non-interventional cohort study to evaluate the safety and treatment pattern of sodium zirconium cyclosilicate for hyperkalaemia management in real world practice in China

Medical condition

Hyperkalaemia

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 22 Mar 2022
Primary Completion Date: 06 Dec 2023
Study Completion Date: 06 Dec 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria